Literature DB >> 15340850

Efflux properties of basolateral peptide transporter in human intestinal cell line Caco-2.

Megumi Irie1, Tomohiro Terada, Masahiro Okuda, Ken-Ichi Inui.   

Abstract

Small peptides and some pharmacologically active compounds are absorbed from the small intestine by the apical H(+)-coupled peptide transporter 1 (PEPT1) and the basolateral peptide transporter. Here we investigated the efflux properties of the basolateral peptide transporter in Caco-2 cells using two strategies, efflux measurements and a kinetic analysis of transepithelial transport of glycylsarcosine (Gly-Sar). [(14)C]Gly-Sar efflux through the basolateral membrane was not affected significantly by the external pH. Both approaches revealed that the basolateral peptide transporter was saturable in the efflux direction, and that the affinity was lower than that in the influx direction. For two peptide-like drugs, there was no difference in substrate recognition by the basolateral peptide transporter between the two sides of the membrane. Using the kinetic parameters of PEPT1 and the basolateral peptide transporter, a computational model of Gly-Sar transport in Caco-2 cells was constructed. The simulation fitted the experimental data well. Our findings suggested that substrate affinity of the basolateral peptide transporter is apparently asymmetric, but pH-dependence and substrate specificity are symmetric for the two directions of transport. The behaviour of Gly-Sar in Caco-2 cells could be predicted by a mathematical model describing the peptide transporters.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15340850     DOI: 10.1007/s00424-004-1326-x

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  26 in total

1.  Role of individual ionic current systems in ventricular cells hypothesized by a model study.

Authors:  Satoshi Matsuoka; Nobuaki Sarai; Shinobu Kuratomi; Kyoichi Ono; Akinori Noma
Journal:  Jpn J Physiol       Date:  2003-04

2.  Kinetic analysis of tetraethylammonium transport in the kidney epithelial cell line, LLC-PK1.

Authors:  Y Tomita; Y Otsuki; Y Hashimoto; K Inui
Journal:  Pharm Res       Date:  1997-09       Impact factor: 4.200

3.  Dose-dependent absorption and elimination of cefadroxil in man.

Authors:  T M Garrigues; U Martin; J E Peris-Ribera; L F Prescott
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

4.  Secretory mechanisms of grepafloxacin and levofloxacin in the human intestinal cell line caco-2.

Authors:  H Yamaguchi; I Yano; Y Hashimoto; K I Inui
Journal:  J Pharmacol Exp Ther       Date:  2000-10       Impact factor: 4.030

5.  Recognition and transport characteristics of nonpeptidic compounds by basolateral peptide transporter in Caco-2 cells.

Authors:  M Irie; T Terada; K Sawada; H Saito; K Inui
Journal:  J Pharmacol Exp Ther       Date:  2001-08       Impact factor: 4.030

6.  Transepithelial transport of oral cephalosporins by monolayers of intestinal epithelial cell line Caco-2: specific transport systems in apical and basolateral membranes.

Authors:  K Inui; M Yamamoto; H Saito
Journal:  J Pharmacol Exp Ther       Date:  1992-04       Impact factor: 4.030

7.  Bidirectional electrogenic transport of peptides by the proton-coupled carrier PEPT1 in Xenopus laevis oocytes: its asymmetry and symmetry.

Authors:  G Kottra; H Daniel
Journal:  J Physiol       Date:  2001-10-15       Impact factor: 5.182

8.  The Na+-independent D-glucose transporter in the enterocyte basolateral membrane: orientation and cytochalasin B binding characteristics.

Authors:  D D Maenz; C I Cheeseman
Journal:  J Membr Biol       Date:  1987       Impact factor: 1.843

9.  Dipeptide transporters in apical and basolateral membranes of the human intestinal cell line Caco-2.

Authors:  H Saito; K Inui
Journal:  Am J Physiol       Date:  1993-08

10.  Transcellular transport of oral cephalosporins in human intestinal epithelial cells, Caco-2: interaction with dipeptide transport systems in apical and basolateral membranes.

Authors:  S Matsumoto; H Saito; K Inui
Journal:  J Pharmacol Exp Ther       Date:  1994-08       Impact factor: 4.030

View more
  7 in total

1.  Prediction of glycylsarcosine transport in Caco-2 cell lines expressing PEPT1 at different levels.

Authors:  Megumi Irie; Tomohiro Terada; Masahiro Tsuda; Toshiya Katsura; Ken-Ichi Inui
Journal:  Pflugers Arch       Date:  2005-11-10       Impact factor: 3.657

2.  Clinical relevance of intestinal peptide uptake.

Authors:  Hugh James Freeman
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-05-06

Review 3.  Di- and tripeptide transport in vertebrates: the contribution of teleost fish models.

Authors:  Tiziano Verri; Amilcare Barca; Paola Pisani; Barbara Piccinni; Carlo Storelli; Alessandro Romano
Journal:  J Comp Physiol B       Date:  2016-11-01       Impact factor: 2.200

4.  Transport mechanisms of carnosine in SKPT cells: contribution of apical and basolateral membrane transporters.

Authors:  Dilara Jappar; Yongjun Hu; Richard F Keep; David E Smith
Journal:  Pharm Res       Date:  2008-09-27       Impact factor: 4.200

Review 5.  Teleost fish models in membrane transport research: the PEPT1(SLC15A1) H+-oligopeptide transporter as a case study.

Authors:  Alessandro Romano; Amilcare Barca; Carlo Storelli; Tiziano Verri
Journal:  J Physiol       Date:  2013-08-27       Impact factor: 5.182

Review 6.  Evaluating Human Intestinal Cell Lines for Studying Dietary Protein Absorption.

Authors:  Paulus G M Jochems; Johan Garssen; Antonius M van Keulen; Rosalinde Masereeuw; Prescilla V Jeurink
Journal:  Nutrients       Date:  2018-03-07       Impact factor: 5.717

Review 7.  Current Evidence on the Bioavailability of Food Bioactive Peptides.

Authors:  Lourdes Amigo; Blanca Hernández-Ledesma
Journal:  Molecules       Date:  2020-09-29       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.